Educational purposes only. Not investment advice. Past performance does not guarantee future results. View full terms

CTRA

Coterra Energy Inc. β€’ Energy (#2 of 11)

$33.92
-1.22 (-3.47%)
View:
Close:$33.92
Vol:NORMAL(35%ile)
Ratio:0.74x
|
RSI:56(Neutral)
MACD:↑
β‰₯75%25-75%<25%
Vol.%
Sector Rotation
2026-04-01(10/10)
20d Strength (bar)
Strong (Β±4%)
Normal (-2~+3%)
5d Strength (normal: -1~+1%)
Relative Strength Trajectory
5d Strength
10d Strength
20d Strength
NASDAQ
10d early: 3~5%|20d confirm: 4~8.5%|>8.5% exhaustion
Analyst Actions
NEUTRAL
β–²0 Upβ–Ό0 Down6 Hold
Mar 30Citigroup
–Buy
Mar 17Mizuho
–Outperform
Mar 16Barclays
–Overweight
Mar 12Piper Sandler
–Overweight
Mar 5Piper Sandler
–Overweight
Mar 5UBS
–Buy
Price Targets
(60d mean: $39, +14.6%)
BULLISH
β–²6 Raisesβ–Ό0 Lowers+17.2% avg
Mar 30Citigroup
$32β†’$42+31.3%
Mar 17Mizuho
$36β†’$43+19.4%
Mar 16Barclays
$34β†’$37+8.8%
Mar 12Piper Sandler
$41β†’$47+14.6%
Mar 5Piper Sandler
$36β†’$41+13.9%
Mar 5UBS
$33β†’$38+15.2%
Trade Setup
Entry$33.92
Target$38.45 (+13.4%)
Stop$31.66
R/R2.00
Risk-6.7%
Conv72 (MEDIUM)
Size195 shares ($6,614)
Risk Metrics
Sharpe (20d)
4.87Excellent
Volatility (20d)
29.8%Normal
Beta (60d)
-0.53Defensive
Alpha (20d)
+16.0%Strong
News Analysis7 articles
EN
δΈ­
ν•œ
ζ—₯
medium termWEAK BUY
Facts12
Assump.10
Exec.11
Surv.15
Value9
Coterra Energy is in a transitional state as it approaches an acquisition by Devon Energy. The deal is confirmed at the CEO level and positively framed by Devon management, but CTRA's stock has shown consistent near-term weakness relative to both the market and the deal narrative. A shareholder litigation investigation by Halper Sadeh introduces modest but real legal uncertainty around deal fairness, which is underappreciated in current coverage. Macro oil price pressure from geopolitical de-escalation is providing a sector-wide headwind independent of company-specific developments. The bullish analyst coverage on Devon (the acquirer) does not directly validate CTRA's standalone value or confirm deal economics are favorable to CTRA shareholders. Investors should treat the merger synergy narrative as unverified until deal terms, structure, and integration plans are disclosed with greater specificity.
Read more...